HeimIMGN • BMV
add
ImmunoGen Ord Shs
Við síðustu lokun
268,50 $
Árabil
268,50 $ - 268,50 $
Markaðsvirði
8,72 ma. USD
V/H-hlutf.
-
A/V-hlutfall
-
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | sep. 2023info | Breyting á/á |
|---|---|---|
Tekjur | 113,42 m. | 637,72% |
Rekstrarkostnaður | 37,74 m. | 12,26% |
Nettótekjur | 30,75 m. | 139,54% |
Hagnaðarhlutfall | 27,11 | 105,36% |
Hagnaður á hvern hlut | 0,10 | 132,26% |
EBITDA | 26,38 m. | 134,26% |
Virkt skatthlutfall | -3,94% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | sep. 2023info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 605,54 m. | 95,64% |
Heildareignir | 822,10 m. | 129,13% |
Heildarskuldir | 260,50 m. | 44,09% |
Eigið fé alls | 561,60 m. | — |
Útistandandi hlutabréf | 266,26 m. | — |
Eiginfjárgengi | 127,25 | — |
Arðsemi eigna | 8,45% | — |
Ávöxtun eigin fjár | 10,17% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | sep. 2023info | Breyting á/á |
|---|---|---|
Nettótekjur | 30,75 m. | 139,54% |
Handbært fé frá rekstri | 2,77 m. | 104,31% |
Reiðufé frá fjárfestingum | -1,35 m. | -124,92% |
Reiðufé frá fjármögnun | 32,13 m. | 7.056,35% |
Breyting á handbæru fé | 33,55 m. | 152,12% |
Frjálst peningaflæði | -2,32 m. | 91,72% |
Um
ImmunoGen, Inc. was a biotechnology company focused on the development of antibody-drug conjugate therapeutics for the treatment of cancer. ImmunoGen was founded in 1981 and was headquartered in Waltham, Massachusetts.
An ImmunoGen ADC contains a manufactured antibody that binds to a target found on cancer cells, with one of the company's potent cell-killing agents attached as a "payload". The antibody serves to deliver the cell-killing agent specifically to cancer cells bearing its target and the payload serves to kill these cells. In some cases, the antibody also has anticancer activity.
In November 2023, AbbVie, an American pharmaceutical company, announced it was buying ImmunoGen for $10.1 billion. Wikipedia
Framkvæmdastjóri
Stofnsett
1981
Höfuðstöðvar
Vefsvæði
Starfsfólk
277
